Clinical trial
ARVs to Prevent Breastmilk HIV:Viral and Immune Responses
NCT00167674 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00167674 |
|---|---|
| Title | ARVs to Prevent Breastmilk HIV:Viral and Immune Responses |
| Official title | ARVs to Prevent Breastmilk HIV:Viral and Immune Responses |
| Lead sponsor | University of Washington, Other |
| Collaborators | Elizabeth Glaser Pediatric AIDS Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Combined short-course zidovudine/nevirapine, HAART |
| Enrollment | 58 |
| Start date | Nov 3, 2003 |
| Primary completion | Mar 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 15, 2025 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: